Insider trading

Period: 120 months Stock: MDT + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

96 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

96 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

96 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

96 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
96 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
96 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

96 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
29 May 2020
Surface Carol A SVP, Chief HR Officer
Sold, plan not stated
$195.44K 2,000 at 97.72
4.0%
20 Feb 2020
ISHRAK OMAR Chairman & CEO
Bought
$997.09K 8,771 at 113.68
1.5%
First buy on file
24 Dec 2019
Kuntz Richard SVP & Chief Medical & Science
Sold, plan not stated 5×
$5.78M 50,856 at 113.58
41.7%
6 Dec 2019
Bought
$566.45K 5,000 at 113.29
5.5%
First buy on file
2 Dec 2019
WHITE ROBERT JOHN EVP & President MITG
Sold, plan not stated 4×
$5.77M 52,166 at 110.62
50.0%
Sold half or more
15 Nov 2019
COYLE MICHAEL J EVP & Group Pres, Cardiac&Vasc
Sold, plan not stated 3×
$4.10M 36,874 at 111.25
16.4%
14 Nov 2019
COYLE MICHAEL J EVP & Group Pres, Cardiac&Vasc
Sold, plan not stated 2×
$230.73K 2,102 at 109.77
1.1%
1 Nov 2019
WHITE ROBERT JOHN EVP & President MITG
Sold, plan not stated 5×
$5.70M 52,165 at 109.33
50.0%
Sold half or more
1 Nov 2019
COYLE MICHAEL J EVP & Group Pres, Cardiac&Vasc
Sold, plan not stated 2×
$4.27M 38,976 at 109.50
17.2%
27 Sep 2019
Kuntz Richard SVP & Chief Medical & Science
Sold, plan not stated 2×
$2.30M 21,425 at 107.51
21.4%
10 Sep 2019
HAKAMI HOOMAN EVP & Group President Diabetes
Sold, plan not stated 9×
$8.89M 82,877 at 107.31
72.9%
Sold half or more
5 Aug 2019
Lerman Bradley E SVP General Counsel & Corp Sec
Sold, plan not stated
$401.24K 4,000 at 100.31
7.0%
2 Aug 2019
Lerman Bradley E SVP General Counsel & Corp Sec
Sold, plan not stated
$673.23K 6,599 at 102.02
10.4%
2 Aug 2019
Kuntz Richard SVP & Chief Medical & Science
Sold, plan not stated
$583.45K 5,719 at 102.02
5.4%
22 Jul 2019
Kuntz Richard SVP & Chief Medical & Science
Sold, plan not stated
$347.65K 3,438 at 101.12
3.3%
17 Jun 2019
Surface Carol A SVP, Chief HR Officer
Sold, plan not stated
$878.98K 9,000 at 97.66
20.9%
12 Jun 2019
HAKAMI HOOMAN EVP & Group President Diabetes
Sold, plan not stated 2×
$5.13M 52,664 at 97.49
55.2%
Sold half or more
6 Jun 2019
Martha Geoffrey EVP & GroupPres Restora Therap
Sold, plan not stated
$1.06M 11,000 at 96.05
18.4%
28 May 2019
TEN HOEDT ROB EVP & President EMEA
Sold, plan not stated
$826.92K 9,000 at 91.88
13.3%
24 May 2019
Bought
$1.01M 10,900 at 92.40
13.8%
First buy on file
9 Jan 2019
ISHRAK OMAR Chairman & CEO
Bought
$1.01M 12,000 at 84.05
2.1%
First buy on file
9 Jan 2019
PARKHILL KAREN L EVP & Chief Financial Officer
Bought
$251.61K 3,000 at 83.87
3.7%
First buy on file
24 Sep 2018
Martha Geoffrey EVP & GroupPres Restora Therap
Sold, plan not stated
$4.88M 49,799 at 97.93
45.7%
31 Aug 2018
HAKAMI HOOMAN EVP & Group President Diabetes
Sold, plan not stated
$2.52M 26,159 at 96.29
29.5%
28 Aug 2018
Kuntz Richard SVP & Chief Medical & Science
Sold, plan not stated
$4.52M 47,176 at 95.88
30.9%
23 Aug 2018
POZEN ROBERT C Director
Sold, plan not stated
$308.74K 3,218 at 95.94
5.0%
23 Aug 2018
Bought
$249.29K 2,600 at 95.88
3.5%
First buy on file
22 Aug 2018
COYLE MICHAEL J EVP & Group Pres, Cardiac&Vasc
Sold, plan not stated
$13.90M 145,544 at 95.50
42.1%
11 Jun 2018
Lerman Bradley E SVP General Counsel & Corp Sec
Sold, plan not stated
$773.57K 8,910 at 86.82
14.7%
8 Jun 2018
Kuntz Richard SVP & Chief Medical & Science
Sold, plan not stated
$1.00M 11,500 at 87.13
9.8%
13 Mar 2018
Lenehan James T Director
Sold, plan not stated
$109.12K 1,306 at 83.56
2.7%
5 Mar 2018
Surface Carol A SVP, Chief HR Officer
Sold, plan not stated
$977.85K 12,479 at 78.36
29.7%
2 Mar 2018
Surface Carol A SVP, Chief HR Officer
Sold, plan not stated
$936.00K 12,000 at 78.00
22.2%
9 Jan 2018
Kuntz Richard SrVP & Chief Scien, Clin, Reg
Sold, plan not stated
$6.77M 78,526 at 86.21
40.1%
5 Jan 2018
HAKAMI HOOMAN EVP & Group President Diabetes
Sold, plan not stated
$2.22M 26,158 at 85.00
28.4%
15 Dec 2017
Hanson Bryan C EVP, President, MITG
Sold, plan not stated
$1.33M 16,000 at 82.82
15.3%
16 Nov 2017
Hanson Bryan C EVP, President, MITG
Sold, plan not stated
$1.26M 16,000 at 79.02
12.8%
16 Oct 2017
Hanson Bryan C EVP, President, MITG
Sold, plan not stated
$1.25M 16,000 at 78.03
11.4%
15 Sep 2017
ISHRAK OMAR Chairman & CEO
Sold, plan not stated
$11.46M 140,407 at 81.63
21.0%
17 Jul 2017
Hanson Bryan C EVP, President, MITG
Sold, plan not stated
$1.06M 12,000 at 88.57
8.1%
21 Jun 2017
Bought
$497.84K 5,600 at 88.90
8.4%
First buy on file
20 Mar 2017
TEN HOEDT ROB EVP & President EMEA
Sold, plan not stated
$4.14M 50,757 at 81.58
49.8%
15 Mar 2017
ISHRAK OMAR Chairman & CEO
Sold, plan not stated
$7.87M 95,000 at 82.82
14.7%
2 Mar 2017
HAKAMI HOOMAN EVP & Group President Diabetes
Sold, plan not stated
$4.31M 52,316 at 82.33
47.0%
13 Dec 2016
POZEN ROBERT C Director
Bought
$999.98K 13,660 at 73.21
25.5%
First buy on file
23 Nov 2016
Lenehan James T Director
Bought
$146.53K 2,000 at 73.27
5.2%
First buy on file
Showing 51–96 of 96. ← Newer Page 2 of 2